StreetInsider.com News Articles

Rise Nano Optics plans C$5M private placement to fund lens tech

Thu, 22 Oct 2026 07:03:26 -0400

Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) announced a proposed non-brokered private placement of up to 10,000,000 units at C$0.50 per unit, targeting gross proceeds of up to C$5,000,000, with a minimum financing amount of C$3,000,000.

Each unit consists of one common share and one warrant. Each warrant entitles the holder to acquire one additional share at C$1.00 for 24 months following the applicable closing date. The offering is expected to close on or about December 15, 2026, subject to standard conditions including board approval and Canadian Securities Exchange requirements.

The company intends to use the proceeds to advance

Rise Nano Optics plans C$5M private placement to fund lens tech

Thu, 22 Oct 2026 07:03:26 -0400

The company intends to use the proceeds to advance

Rise Nano Optics Announces Proposed Non-Brokered Private Placement of Up to C$5 Million

Thu, 22 Oct 2026 07:00:00 -0400

Financing intended to accelerate SpectraGuard™ commercialization, expand optical industry partnerships and support manufacturing growth

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Recent Highlights:

FDA Registration: Rise successfully completed FDA Class 1 Medical Device Classification and Registration for SpectraGuard.
Two Optical Lab Partnerships: Established strategic partnerships with Sierra Optical Lab and Sportifeye Optics in the USA to produce and commercialize SpectraGuard treated lenses. Two production lines have now been installed and operationalized.
First Clinical Channel Partnership: Signed first USA-based eye care professional partnership with LI Opticians to carry SpectraGuard.

Rise Nano Optics Announces Proposed Non-Brokered Private Placement of Up to C$5 Million

Thu, 22 Oct 2026 07:00:00 -0400

Financing intended to accelerate SpectraGuard™ commercialization, expand optical industry partnerships and support manufacturing growth

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Recent Highlights:

FDA Registration: Rise successfully completed FDA Class 1 Medical Device Classification and Registration for SpectraGuard.
Two Optical Lab Partnerships: Established strategic partnerships with Sierra Optical Lab and Sportifeye Optics in the USA to produce and commercialize SpectraGuard treated lenses. Two production lines have now been installed and operationalized.
First Clinical Channel Partnership: Signed first USA-based eye care professional partnership with LI Opticians to carry SpectraGuard.

Rise Nano Optics Announces Proposed Non-Brokered Private Placement of Up to C$5 Million

Thu, 22 Oct 2026 07:00:00 -0400

Financing intended to accelerate SpectraGuard™ commercialization, expand optical industry partnerships and support manufacturing growth

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Recent Highlights:

FDA Registration: Rise successfully completed FDA Class 1 Medical Device Classification and Registration for SpectraGuard.
Two Optical Lab Partnerships: Established strategic partnerships with Sierra Optical Lab and Sportifeye Optics in the USA to produce and commercialize SpectraGuard treated lenses. Two production lines have now been installed and operationalized.
First Clinical Channel Partnership: Signed first USA-based eye care professional partnership with LI Opticians to carry SpectraGuard.

Rise Nano Optics Announces Proposed Non-Brokered Private Placement of Up to C$5 Million

Thu, 22 Oct 2026 07:00:00 -0400

Financing intended to accelerate SpectraGuard™ commercialization, expand optical industry partnerships and support manufacturing growth

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Recent Highlights:

FDA Registration: Rise successfully completed FDA Class 1 Medical Device Classification and Registration for SpectraGuard.
Two Optical Lab Partnerships: Established strategic partnerships with Sierra Optical Lab and Sportifeye Optics in the USA to produce and commercialize SpectraGuard treated lenses. Two production lines have now been installed and operationalized.
First Clinical Channel Partnership: Signed first USA-based eye care professional partnership with LI Opticians to carry SpectraGuard.

National Vision Launches 2026-2027 Scholarship Program, Exploring the Balance Between Innovation and Human Connection

Mon, 12 Oct 2026 08:04:00 -0400

Annual Program Marks Its 12th Year With $12,500 in Scholarships for Future Optometrists

ALPHARETTA, Ga.--(BUSINESS WIRE)--

National Vision Holdings, Inc. (NASDAQ: EYE), one of the largest optical retail companies in the United States, announced today that its annual scholarship program is open for entries, offering eligible optometry students the opportunity to win up to $7,500.

This year’s scholarship program challenges students to explore the topic of, “Balancing Innovation and Human Connection.” Third- and fourth-year optometry students are invited to submit written or video essays examining how optometrists can embrace new technologies and tools while preserving the trust,

National Vision Launches 2026-2027 Scholarship Program, Exploring the Balance Between Innovation and Human Connection

Mon, 12 Oct 2026 08:04:00 -0400

Annual Program Marks Its 12th Year With $12,500 in Scholarships for Future Optometrists

ALPHARETTA, Ga.--(BUSINESS WIRE)--

Form SCHEDULE 13G National Vision Holdings Filed by: DIMENSIONAL FUND ADVISORS LP

Thu, 08 Oct 2026 14:26:00 -0400

si-local-file:///var/storage/secattach/20261008/27166501.html

Rise Nano Optics to Attend the 2026 Cantech Investment Conference in Toronto

Thu, 01 Oct 2026 07:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - October 1, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, is pleased to announce that members of its management team will attend the 2026 Cantech Investment Conference on October 8, 2026, in Toronto, Ontario.

The Cantech Investment Conference is one of Canada's leading capital markets technology events, bringing together emerging technology companies, institutional and retail investors, analysts, investment bankers and other capital markets professionals. The 2026 conference is sold out for presenting companies and will be held

Rise Nano Optics to Attend the 2026 Cantech Investment Conference in Toronto

Thu, 01 Oct 2026 07:00:00 -0400

Rise Nano Optics to Attend the 2026 Cantech Investment Conference in Toronto

Thu, 01 Oct 2026 07:00:00 -0400

Rise Nano Optics to Attend the 2026 Cantech Investment Conference in Toronto

Thu, 01 Oct 2026 07:00:00 -0400

Rise Nano Optics to Sponsor INVISION MATCH! 2026, Connecting SpectraGuard with Leading Independent Eye Care Practices

Thu, 24 Sep 2026 07:00:00 -0400

Company to participate in curated one-on-one meetings with leading independent optometry practice owners as it expands U.S. commercialization of SpectraGuard(TM)

Vancouver, British Columbia--(Newsfile Corp. - September 24, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that it will participate as a sponsor of INVISION MATCH! 2026, an invite-only industry event designed to connect leading independent optometry practice owners with innovative optical industry suppliers through curated, one-on-one business meetings.

The inaugural INVISION MATCH! will take place September 30 through October 2, 2026,

Rise Nano Optics to Sponsor INVISION MATCH! 2026, Connecting SpectraGuard with Leading Independent Eye Care Practices

Thu, 24 Sep 2026 07:00:00 -0400

Company to participate in curated one-on-one meetings with leading independent optometry practice owners as it expands U.S. commercialization of SpectraGuard(TM)
Vancouver, British Columbia--(Newsfile Corp. - September 24, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that it will participate as a sponsor of INVISION MATCH! 2026, an invite-only industry event designed to connect leading independent optometry practice owners with innovative optical industry suppliers through curated, one-on-one business meetings.
The inaugural INVISION MATCH! will take place September 30 through October 2, 2026,

Rise Nano Optics to Sponsor INVISION MATCH! 2026, Connecting SpectraGuard with Leading Independent Eye Care Practices

Thu, 24 Sep 2026 07:00:00 -0400

Company to participate in curated one-on-one meetings with leading independent optometry practice owners as it expands U.S. commercialization of SpectraGuard(TM)
Vancouver, British Columbia--(Newsfile Corp. - September 24, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that it will participate as a sponsor of INVISION MATCH! 2026, an invite-only industry event designed to connect leading independent optometry practice owners with innovative optical industry suppliers through curated, one-on-one business meetings.
The inaugural INVISION MATCH! will take place September 30 through October 2, 2026,

Rise Nano Optics to Sponsor INVISION MATCH! 2026, Connecting SpectraGuard with Leading Independent Eye Care Practices

Thu, 24 Sep 2026 07:00:00 -0400

Company to participate in curated one-on-one meetings with leading independent optometry practice owners as it expands U.S. commercialization of SpectraGuard(TM)
Vancouver, British Columbia--(Newsfile Corp. - September 24, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that it will participate as a sponsor of INVISION MATCH! 2026, an invite-only industry event designed to connect leading independent optometry practice owners with innovative optical industry suppliers through curated, one-on-one business meetings.
The inaugural INVISION MATCH! will take place September 30 through October 2, 2026,

Exclusive: National Vision CEO on traffic, ticket growth and the digital shift

Wed, 23 Sep 2026 15:24:21 -0400

Investing.com – On the surface, National Vision’s second quarter results may look counterintuitive: store traffic fell, yet comparable sales rose, margins expanded, and adjusted EPS grew 40% year over year.
A closer look, however, shows why: a deliberate push toward a slightly different client mix, major e-commerce initiatives, store segmentation programs, even at the cost of slightly lower traffic.
Investing.com had a chance to speak with the company’s CEO Alex Wilkes to get a better idea of what the company has been working on and what investors should expect next.
Traffic is weaker, but client spending is strong
Despite a 4.9% decline in store

Rise Nano Optics to Attend the Vision Council's 2026 Lab Leadership Forum

Wed, 16 Sep 2026 07:00:00 -0400

Sold-out industry forum brings together leaders from the independent optical laboratory sector as Rise advances its lab-first commercialization strategy for SpectraGuard™
Vancouver, British Columbia--(Newsfile Corp. - September 16, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that the Company will attend The Vision Council's 2026 Lab Leadership Forum, taking place September 16-18, 2026, at the M Resort Spa Casino in Henderson, Nevada.
Rise will be represented at the Forum by Erik Ritchie, Chief Commercial Officer, as the Company continues

Rise Nano Optics to Attend the Vision Council's 2026 Lab Leadership Forum

Wed, 16 Sep 2026 07:00:00 -0400

Sold-out industry forum brings together leaders from the independent optical laboratory sector as Rise advances its lab-first commercialization strategy for SpectraGuard™
Vancouver, British Columbia--(Newsfile Corp. - September 16, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that the Company will attend The Vision Council's 2026 Lab Leadership Forum, taking place September 16-18, 2026, at the M Resort Spa Casino in Henderson, Nevada.
Rise will be represented at the Forum by Erik Ritchie, Chief Commercial Officer, as the Company continues

Rise Nano Optics to Attend the Vision Council's 2026 Lab Leadership Forum

Wed, 16 Sep 2026 07:00:00 -0400

Sold-out industry forum brings together leaders from the independent optical laboratory sector as Rise advances its lab-first commercialization strategy for SpectraGuard™
Vancouver, British Columbia--(Newsfile Corp. - September 16, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that the Company will attend The Vision Council's 2026 Lab Leadership Forum, taking place September 16-18, 2026, at the M Resort Spa Casino in Henderson, Nevada.
Rise will be represented at the Forum by Erik Ritchie, Chief Commercial Officer, as the Company continues

Rise Nano Optics to Attend the Vision Council's 2026 Lab Leadership Forum

Wed, 16 Sep 2026 07:00:00 -0400

Sold-out industry forum brings together leaders from the independent optical laboratory sector as Rise advances its lab-first commercialization strategy for SpectraGuard™
Vancouver, British Columbia--(Newsfile Corp. - September 16, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that the Company will attend The Vision Council's 2026 Lab Leadership Forum, taking place September 16-18, 2026, at the M Resort Spa Casino in Henderson, Nevada.
Rise will be represented at the Forum by Erik Ritchie, Chief Commercial Officer, as the Company continues

National Vision Holdings (EYE) PT Lowered to $27 at Guggenheim

Fri, 11 Sep 2026 07:08:33 -0400
Guggenheim analyst Simon Siegel lowered the price target on National Vision Holdings (NASDAQ: EYE) to $27.00 (from $33.00) while maintaining a Buy rating.

National Vision, Inc. Announces Participation in Barclays 19th Annual Global Consumer Conference

Wed, 26 Aug 2026 16:05:00 -0400

ALPHARETTA, Ga.--(BUSINESS WIRE)-- National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that the Company is scheduled to present at the Barclays 19th Annual Global Consumer Conference on Wednesday, September 9, 2026, at 12:45 p.m. Eastern Time.
A live webcast of the presentation will be available in the “Investors” section of the Company’s website at www.ir.nationalvision.com. The webcast will be archived and available on the website shortly after the event.
About National Vision Holdings, Inc.
National Vision Holdings, Inc. (NASDAQ: EYE) is one of the largest optical retail companies in the United

National Vision, Inc. Announces Participation in Barclays 19th Annual Global Consumer Conference

Wed, 26 Aug 2026 16:05:00 -0400

ALPHARETTA, Ga.--(BUSINESS WIRE)-- National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that the Company is scheduled to present at the Barclays 19th Annual Global Consumer Conference on Wednesday, September 9, 2026, at 12:45 p.m. Eastern Time.
A live webcast of the presentation will be available in the “Investors” section of the Company’s website at www.ir.nationalvision.com. The webcast will be archived and available on the website shortly after the event.
About National Vision Holdings, Inc.
National Vision Holdings, Inc. (NASDAQ: EYE) is one of the largest optical retail companies in the United